A carregar...
Effect of switching from natalizumab to moderate- vs high-efficacy DMT in clinical practice
OBJECTIVE: To assess the real-world comparative effectiveness of switching from natalizumab (NTZ) to a moderate-efficacy (Mod) disease-modifying therapy (DMT) vs high-efficacy therapy (HET) in patients with multiple sclerosis (MS). METHODS: Patients discontinuing NTZ at two MS centers (n = 556) who...
Na minha lista:
| Publicado no: | Neurol Clin Pract |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Lippincott Williams & Wilkins
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7837445/ https://ncbi.nlm.nih.gov/pubmed/33510948 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/CPJ.0000000000000809 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|